Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-25 @ 4:04 AM
NCT ID:
NCT03144102
Eligibility Criteria:
Inclusion Criteria:
* Patients with hemiparesis secondary to first ever ischemic or hemorrhagic stroke (Medical Research Council score \> 2).
* Older than 18 years old.
* Sufficient cognitive capacity to understand and follow the experimental instructions (Mini-Mental State Evaluation \> 20).
Exclusion Criteria:
* Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.
* Epilepsia and metal implants. A diagnostic EEG will be performed by the Department of Clinical Neurophysiology of the hospital to detect epileptic paroxysmal in order to include or exclude patients in the study.
* Low Cognitive capabilities that prohibits the execution of the experiment Arteriovenous malformation
* Severe associated impairment such as spasticity, communication disabilities (sensorial, mixed or global aphasia or apraxia), major pain or other neuromuscular impairments or orthopaedic devices that would interfere with the correct execution of the experiment (Modified Ashworth Scale \> 3)
* History of serious mental-health problems in acute or sub acute phase
* Refusal to sign the consent form
* Previous surgeries opening the skull.
* Active or recent substance abuse or dependence within the past year.
* Pregnancy, breastfeeding, unwillingness to practice birth control during participation in the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03144102
Study Brief:
Protocol Section:
NCT03144102